Advertisement

Picture Berlin Partner Hotspot for Startups 650x80px
Organisation › Details

Selvita (Group)

Selvita is a preclinical Contract Research Organization providing multidisciplinary support in resolving the unique challenges of research within area of drug discovery, regulatory studies, as well as research and development. Selvita is also a major shareholder in Ardigen – a bioinformatics company harnessing advanced Artificial Intelligence methods for novel precision medicine. In January 2021, Selvita acquired 100% of shares in Fidelta d.o.o., substantially expanding its scope of drug discovery services in infectious diseases, inflammation, and fibrosis and building a competitive advantage in areas such as DMPK, in vivo pharmacology, and toxicology. Selvita was established in 2007 and currently employs almost 800 professionals, of which over 40% hold a Ph.D. title. Selvita is headquartered in Krakow, Poland, with a second research site in Poznan, Poland, while Fidelta is located in Zagreb, Croatia. Selvita’s international offices are located in Cambridge, MA, and San Francisco Bay Area, in the U.S., as well as in Cambridge, UK. Selvita is listed on the Warsaw Stock Exchange (WSE: SLV). *

 

Period Start 2007-01-01 established
Products Industry drug discovery services
  Industry 2 chemical services
Persons Person Przewiezlikowski, Pawel (Selvita 201309 CEO + Co-Founder)
  Person 2 Sieczkowski, Boguslaw (Selvita 201405 CFO + Co-Founder + key shareholder)
     
Region Region Kraków
  Country Poland
  Street 14 ul. Bobrzynskiego
Park Life Science
  City 31444 Kraków
  Tel +48-12-297-4700
    Address record changed: 2020-12-02
     
Basic data Employees E: 501 to 1,000 (2021-07-19)
  Currency EUR
  Annual sales 13,319,000 (revenues, total, consolidated (2015) 2015-12-31)
  Profit 1,490,000 (2015-12-31)
  Cash 6,760,000 (2015-12-31)
     
    * Document for �About Section�: Selvita S.A.. (7/19/21). "Press Release: Selvita Appoints Dean Bornilla as Vice President of Sales, Head of North America". Krakow.
     
   
Record changed: 2021-07-20

Advertisement

Picture EBD Group Connector Personal Networking in Life Sciences 650x80

More documents for Selvita (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Demy-Colton BioFuture 2021 NYC B Preview Download 650x300px




» top